19/05/2026
Anesthesia in high-ASA-risk patients, especially those with cardiopulmonary disease, requires a very different level of expertise compared to routine general anesthesia for procedures such as dental scaling or neutering.
Beyond standard monitoring such as ECG, blood pressure, SpO₂, and capnography, advanced cases may require invasive arterial blood pressure monitoring, blood gas analysis, meticulous ventilatory management, individualized drug selection, and continuous real-time adjustments throughout the procedure.
Certain anesthetic drugs should be avoided in specific cardiac conditions. Drug selection often depends on cardiac function, pulmonary status, and overall hemodynamic stability, while some agents may be preferred over others in carefully selected patients.
Equally important — yet often overlooked — is post-anesthetic recovery monitoring. In fact, anesthetic-related mortality is highest during the recovery period. Anesthesia is not simply “procedure done, goodbye.” Careful monitoring and support must continue until the patient is truly stable.
There is no single fixed protocol that works for every patient. It is both science and art — balancing perfusion, oxygenation, ventilation, cardiac output, anesthetic depth, and patient safety moment by moment.
对于高 ASA 风险、特别是伴有心肺疾病的病患而言，麻醉管理远比一般洗牙或绝育手术的全身麻醉复杂得多，也更考验麻醉团队的经验与判断能力。
除了常规监测如 ECG（心电图）、血压、SpO₂（血氧饱和度）及 capnography（二氧化碳监测）之外，高风险病例往往还需进行动脉侵入式血压监测、血气分析、精细化呼吸管理，以及依据病患状况量身调整麻醉药物与方案。
在某些心脏疾病中，部分麻醉药物可能并不适合使用；而药物的选择，则需综合考虑心脏功能、肺部状态及整体血流动力学稳定性。有时，同一种药物在不同病患身上，效果与风险也可能截然不同。
此外，术后苏醒期的监护同样极其重要，却经常被忽略。事实上，许多麻醉相关死亡，往往发生在这个关键恢复阶段。因此，麻醉并不是“手术结束就完成了”，而是需要持续监测直到病患真正稳定恢复。
因此，麻醉并不存在所谓“万能公式”或固定流程。它不仅是医学科学，更是一门需要经验与实时判断的艺术 —— 在整个过程中，持续平衡氧合、通气、组织灌流、心输出量、麻醉深度以及病患安全。
